Surgery Partners, Inc.(SGRY)Earnings, Financials & Key Ratios

SGRY•NASDAQ

$14.59

$1.89B mkt cap·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare Facilities Sub-IndustryOutpatient clinics and surgery centers

AboutSurgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.Show more

Revenue$3.31B+6.2%
EBITDA$566M+12.8%
Net Income-$78M+53.7%
EPS (Diluted)-0.61+54.1%
Gross Margin23.12%-3.4%
EBITDA Margin17.09%+6.2%
Operating Margin11.77%+5.1%
Net Margin-2.35%+56.4%
ROE-2.18%+54.7%
ROIC4.06%+3.3%
Debt/Equity1.14+12.0%
Interest Coverage1.43-17.4%

Technical→

SGRY Key Insights

Surgery Partners, Inc. (SGRY) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong 5Y sales CAGR of 12.2%
✓Trading at only 0.5x book value

✗Weaknesses

✗Weak momentum: RS Rating 19 (bottom 19%)
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SGRY Price & Volume

Surgery Partners, Inc. (SGRY) stock price & volume — 10-year historical chart

Loading chart...

SGRY Growth Metrics

Surgery Partners, Inc. (SGRY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years13.17%

5 Years12.21%

3 Years9.22%

TTM5.38%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM60.65%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM61.46%

Return on Capital

10 Years5.28%

5 Years5.45%

3 Years5.19%

Last Year5.23%

SGRY Recent Earnings

Surgery Partners, Inc. (SGRY) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

May 5, 2026

EPS

$0.03

Est $0.15

+80.0%

Revenue

$811M

Est $798M

+1.7%

Q2 2026

Mar 2, 2026

EPS

$0.12

Est $0.31

-61.3%

Revenue

$885M

Est $867M

+2.1%

Q4 2025

Nov 10, 2025

EPS

$0.13

Est $0.19

-31.6%

Revenue

$822M

Est $867M

-5.2%

Q3 2025

Aug 5, 2025

EPS

$0.17

Est $0.16

+6.3%

Revenue

$826M

Est $824M

+0.3%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$0.03vs $0.15+80.0%	$811Mvs $798M+1.7%
Q2 2026	Mar 2, 2026	$0.12vs $0.31-61.3%	$885Mvs $867M+2.1%
Q4 2025	Nov 10, 2025	$0.13vs $0.19-31.6%	$822Mvs $867M-5.2%
Q3 2025	Aug 5, 2025	$0.17vs $0.16+6.3%	$826Mvs $824M+0.3%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
USPHU.S. Physical Therapy, Inc.Direct Competitor	1.12B	73.61	51.84	16.33%	1.52%	1.36%	0.55
SEMSelect Medical Holdings CorporationDirect Competitor	2.04B	16.43	13.92	5.12%	2.42%	6.57%	1.82
AMSFAMERISAFE, Inc.Direct Competitor	556.33M	29.60	11.98	2.63%	14.27%	9.68%	0.00
NHCNational HealthCare CorporationDirect Competitor	2.63B	169.41	22.09	13.23%	6.75%	9.57%	0.08
ADUSAddus HomeCare CorporationDirect Competitor	1.8B	96.64	18.55	23.21%	6.89%	9.34%	0.19
ALHCAlignment Healthcare, Inc.Direct Competitor	3.71B	18.14	-4902.70	46.06%	0.47%	11.5%	1.89
UHSUniversal Health Services, Inc.Product Competitor	10.55B	168.49	7.29	9.71%	8.56%	20.65%	0.74
HCAHCA Healthcare, Inc.Product Competitor	96.01B	429.45	15.13	7.08%	8.97%

Compare SGRY vs Peers

Surgery Partners, Inc. (SGRY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs USPH

Most directly comparable listed peer for SGRY.

Scale Benchmark

vs UNH

Larger-name benchmark to compare SGRY against a more recognizable public peer.

Peer Set

Compare Top 5

vs USPH, SEM, AMSF, NHC

SGRY Income Statement

Surgery Partners, Inc. (SGRY) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	1.34B	1.77B	1.83B	1.86B	2.23B	2.54B	2.74B	3.11B	3.31B	3.34B
Revenue Growth %	17.09%	32.08%	3.38%	1.57%	19.62%	14.12%	8.03%	13.52%	6.24%	5.38%
Cost of Goods Sold	1.01B	1.36B	1.41B	1.48B	1.73B	1.96B	2.1B	2.37B	2.54B	2.58B
COGS % of Revenue	75.59%	76.85%	76.86%	79.58%	77.92%	77.36%	76.4%	76.06%	76.88%	-
Gross Profit	327.42M▲ 0%	410.02M▲ 25.2%	423.8M▲ 3.4%	379.8M▼ 10.4%	491.4M▲ 29.4%	574.9M▲ 17.0%	647.5M▲ 12.6%	745.6M▲ 15.2%	765M▲ 2.6%	763.3M▲ 0%
Gross Margin %	24.41%	23.15%	23.14%	20.42%	22.08%	22.64%	23.6%	23.94%	23.12%	22.83%
Gross Profit Growth %	0.98%	25.23%	3.36%	-10.38%	29.38%	16.99%	12.63%	15.15%	2.6%	-
Operating Expenses	156.37M	157.23M	187.9M	196.8M	189.2M	229.7M	319.5M	396.8M	375.5M	416.1M
OpEx % of Revenue	11.66%	8.88%	10.26%	10.58%	8.5%	9.05%	11.65%	12.74%	11.35%	-
Selling, General & Admin	75.95M	93.56M	88.6M	97.1M	104M	102.2M	120.9M	138.7M	522.7M	627.3M
SG&A % of Revenue	5.66%	5.28%	4.84%	5.22%	4.67%	4.02%	4.41%	4.45%	15.8%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	25.33M	63.67M	99.3M	99.7M	85.2M	127.5M	198.6M	258.1M	-147.2M	-1000K
Operating Income	158.23M▲ 0%	77.84M▼ 50.8%	235.9M▲ 203.1%	183M▼ 22.4%	302.2M▲ 65.1%	345.2M▲ 14.2%	328M▼ 5.0%	348.8M▲ 6.3%	389.5M▲ 11.7%	393.4M▲ 0%
Operating Margin %	11.8%	4.39%	12.88%	9.84%	13.58%	13.59%	11.96%	11.2%	11.77%	11.77%
Operating Income Growth %	-19.47%	-50.81%	203.07%	-22.42%	65.14%	14.23%	-4.98%	6.34%	11.67%	-
EBITDA	210.16M	145.28M	312.4M	277.8M	401M	460M	446.1M	501.4M	565.5M	571.6M
EBITDA Margin %	15.67%	8.2%	17.06%	14.93%	18.02%	18.12%	16.26%	16.1%	17.09%	17.1%
EBITDA Growth %	-10.96%	-30.87%	115.04%	-11.08%	44.35%	14.71%	-3.02%	12.4%	12.78%	16.68%
D&A (Non-Cash Add-back)	51.93M	67.44M	76.5M	94.8M	98.8M	114.8M	118.1M	152.6M	176M	178.2M
EBIT	199.96M	77.8M	233.5M	183M	302.2M	345.2M	328M	348.8M	389.5M	712.8M
Net Interest Income	0	-147M	-178.9M	-201.8M	-221M	-234.9M	-193M	-201.7M	-272.6M	-595.6M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	117.67M	147M	178.9M	201.8M	221M	234.9M	193M	201.7M	272.6M	526.5M
Other Income/Expense	-75.95M	-147M	-181.3M	-201.8M	-221M	-234.9M	-193M	-201.7M	-272.6M	-210.4M
Pretax Income	82.29M▲ 0%	-69.17M▼ 184.1%	54.6M▲ 178.9%	-18.8M▼ 134.4%	81.2M▲ 531.9%	110.3M▲ 35.8%	135M▲ 22.4%	147.1M▲ 9.0%	116.9M▼ 20.5%	113.9M▲ 0%
Pretax Margin %	6.14%	-3.9%	2.98%	-1.01%	3.65%	4.34%	4.92%	4.72%	3.53%	3.41%
Income Tax	53.55M	26.46M	9.5M	-20.1M	10.5M	23.3M	-300K	134.6M	18M	19.2M
Effective Tax Rate %	65.08%	-38.26%	17.4%	106.91%	12.93%	21.12%	-0.22%	91.5%	15.4%	16.86%
Net Income	-52.98M▲ 0%	-205.71M▼ 288.2%	-74.8M▲ 63.6%	-116.1M▼ 55.2%	-70.9M▲ 38.9%	-54.6M▲ 23.0%	-11.9M▲ 78.2%	-168.1M▼ 1312.6%	-77.9M▲ 53.7%	-76.1M▲ 0%
Net Margin %	-3.95%	-11.61%	-4.08%	-6.24%	-3.19%	-2.15%	-0.43%	-5.4%	-2.35%	-2.28%
Net Income Growth %	-660.51%	-288.23%	63.64%	-55.21%	38.93%	22.99%	78.21%	-1312.61%	53.66%	60.65%
Net Income (Continuing)	28.74M	-95.6M	45.1M	1.3M	70.7M	87M	135.3M	12.5M	98.9M	63.3M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	681.88M	694.3M	1.01B	1.07B	1.21B	1.28B	1.37B	1.85B	1.81B	383.4M
EPS (Diluted)	-1.08▲ 0%	-4.28▼ 296.3%	0.95▲ 122.2%	-3.19▼ 435.8%	-1.12▲ 64.9%	-0.59▲ 47.3%	-0.09▲ 83.9%	-1.33▼ 1304.4%	-0.61▲ 54.1%	-0.59▲ 0%
EPS Growth %	-640%	-296.3%	122.2%	-435.79%	64.89%	47.32%	83.95%	-1304.44%	54.14%	61.46%
EPS (Basic)	-1.09	-4.28	0.95	-3.19	-1.12	-0.59	-0.09	-1.33	-0.61	-
Diluted Shares Outstanding	49M	48.03M	48.28M	48.78M	72.43M	91.95M	125.61M	126.12M	127.21M	128.37M
Basic Shares Outstanding	48.69M	48.03M	48.28M	48.78M	72.43M	91.95M	125.61M	126.12M	127.21M	128.37M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

SGRY Balance Sheet

Surgery Partners, Inc. (SGRY) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	563.23M	588.32M	525.5M	801.5M	946.1M	921M	895M	1.12B	1.15B	1.08B
Cash & Short-Term Investments	174.91M	184.31M	92.7M	317.9M	389.9M	282.9M	195.9M	269.5M	239.9M	182.3M
Cash Only	174.91M	184.31M	92.7M	317.9M	389.9M	282.9M	195.9M	269.5M	239.9M	182.3M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	295.62M	316.14M	326.9M	382.2M	430.2M	456.3M	496.4M	579.1M	602.2M	0
Days Sales Outstanding	80.45	65.14	65.15	75	70.57	65.59	66.05	67.87	66.43	47.61
Inventory	44.95M	43.36M	46.3M	56.4M	61.1M	71.4M	75.2M	88.4M	96.6M	0
Days Inventory Outstanding	16.18	11.63	12.01	13.91	12.86	13.27	13.1	13.62	13.86	9.77
Other Current Assets	30.9M	28.28M	41.8M	27.4M	39.3M	79M	96.5M	182.4M	170.9M	900.2M
Total Non-Current Assets	4.06B	4.09B	4.49B	4.61B	5.17B	5.76B	5.98B	6.77B	7.09B	6.96B
Property, Plant & Equipment	398.54M	426.29M	821M	854.7M	953.8M	1.16B	1.22B	1.38B	1.44B	0
Fixed Asset Turnover	3.37x	4.16x	2.23x	2.18x	2.33x	2.20x	2.24x	2.25x	2.29x	3.09x
Goodwill	3.35B	3.38B	3.4B	3.47B	3.91B	4.14B	4.33B	5.07B	5.19B	0
Intangible Assets	58.91M	54.29M	47.3M	46.9M	43.7M	42.3M	54.8M	45.7M	41M	0
Long-Term Investments	74.28M	78.48M	93.2M	90.3M	88.7M	190.3M	184.1M	215.4M	234M	683.6M
Other Non-Current Assets	48.66M	36.85M	30.8M	27M	59.1M	144.2M	103.3M	57.5M	56.8M	7.1B
Total Assets	4.62B▲ 0%	4.68B▲ 1.2%	5.02B▲ 7.3%	5.41B▲ 7.9%	6.12B▲ 13.0%	6.68B▲ 9.2%	6.88B▲ 2.9%	7.89B▲ 14.7%	8.24B▲ 4.5%	8.04B▲ 0%
Asset Turnover	0.29x	0.38x	0.36x	0.34x	0.36x	0.38x	0.40x	0.39x	0.40x	0.42x
Asset Growth %	100.56%	1.16%	7.33%	7.86%	13.01%	9.23%	2.91%	14.74%	4.46%	17.33%
Total Current Liabilities	303M	349.3M	398.1M	556.8M	536.8M	493.4M	523M	624.4M	615.5M	581.7M
Accounts Payable	84.71M	83.29M	96.7M	100.2M	124.9M	151.6M	171.8M	208.7M	208.7M	0
Days Payables Outstanding	30.5	22.33	25.07	24.71	26.3	28.17	29.92	32.16	29.95	19.74
Short-Term Debt	58.73M	55.6M	56M	64.4M	60.4M	62.8M	73.3M	101.4M	142M	100.4M
Deferred Revenue (Current)	-143.44M	-138.84M	0	109.8M	64.4M	3.2M	0	0	0	0
Other Current Liabilities	19.48M	135.19M	22.5M	38.1M	47.3M	49.1M	23.9M	24.8M	199.9M	481.3M
Current Ratio	1.86x	1.68x	1.32x	1.44x	1.76x	1.87x	1.71x	1.79x	1.87x	1.87x
Quick Ratio	1.71x	1.56x	1.20x	1.34x	1.65x	1.72x	1.57x	1.65x	1.71x	1.71x
Cash Conversion Cycle	66.14	54.43	52.08	64.2	57.14	50.69	49.22	49.33	50.35	37.64
Total Non-Current Liabilities	2.98B	2.54B	2.92B	3.23B	3.28B	2.91B	2.99B	3.63B	4.1B	3.98B
Long-Term Debt	2.13B	2.25B	2.52B	2.79B	2.88B	2.56B	2.7B	3.27B	2.71B	271.9M
Capital Lease Obligations	121.63M	166.34M	283.1M	300.9M	315.6M	271.4M	248.9M	292.1M	1.18B	2.58B
Deferred Tax Liabilities	28.38M	52.28M	0	0	0	0	0	39.2M	175.7M	255.7M
Other Non-Current Liabilities	100.85M	121.49M	113.6M	139.7M	87M	75.4M	41.1M	30.2M	41.2M	4.09B
Total Liabilities	4.62B	4.68B	3.32B	3.79B	3.82B	3.4B	3.51B	4.25B	4.72B	4.56B
Total Debt	2.19B	2.48B	2.9B	3.2B	3.29B	2.93B	3.06B	3.7B	4.02B	372.3M
Net Debt	2.01B	2.29B	2.81B	2.88B	2.9B	2.65B	2.87B	3.43B	3.78B	190M
Debt / Equity	1.64x	2.25x	1.71x	1.97x	1.43x	0.89x	0.91x	1.02x	1.14x	1.14x
Debt / EBITDA	10.42x	17.04x	9.29x	11.51x	8.22x	6.37x	6.86x	7.39x	7.12x	0.65x
Net Debt / EBITDA	9.58x	15.78x	8.99x	10.36x	7.24x	5.75x	6.42x	6.85x	6.69x	6.69x
Interest Coverage	1.70x	0.53x	1.31x	0.91x	1.37x	1.47x	1.70x	1.73x	1.43x	1.35x
Total Equity	1.34B▲ 0%	1.1B▼ 17.8%	1.7B▲ 54.6%	1.62B▼ 4.5%	2.3B▲ 41.7%	3.28B▲ 42.7%	3.36B▲ 2.4%	3.64B▲ 8.1%	3.53B▼ 3.0%	2.07B▲ 0%
Equity Growth %	311.68%	-17.78%	54.64%	-4.47%	41.67%	42.75%	2.41%	8.13%	-2.98%	-46.19%
Book Value per Share	27.28	22.88	35.20	33.28	31.75	35.70	26.76	28.82	27.72	16.14
Total Shareholders' Equity	654.73M	404.64M	691.8M	550.1M	1.09B	2B	1.99B	1.79B	1.71B	1.69B
Common Stock	487K	489K	500K	500K	900K	1.3M	1.3M	1.3M	1.3M	1.3M
Retained Earnings	-41.32M	-247.02M	-315.7M	-431.8M	-502.7M	-557.3M	-569.2M	-737.3M	-815.2M	-851.1M
Treasury Stock	0	33K	0	0	0	0	0	0	0	0
Accumulated OCI	-19.68M	-22.45M	-50.7M	-61M	-31.5M	76.2M	57.5M	4.8M	-13.8M	-10.5M
Minority Interest	681.88M	694.3M	1.01B	1.07B	1.21B	1.28B	1.37B	1.85B	1.81B	383.4M

SGRY Cash Flow Statement

Surgery Partners, Inc. (SGRY) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	120.94M	144.6M	129.5M	246.9M	87.1M	158.8M	293.8M	300.1M	274.3M	274.3M
Operating CF Margin %	9.02%	8.16%	7.07%	13.27%	3.91%	6.25%	10.71%	9.64%	8.29%	-
Operating CF Growth %	-3.43%	19.56%	-10.44%	90.66%	-64.72%	82.32%	85.01%	2.14%	-8.6%	114.23%
Net Income	-52.98M	-95.63M	45.1M	1.3M	70.7M	87M	135.3M	12.5M	98.9M	-76.1M
Depreciation & Amortization	51.93M	67.44M	76.5M	94.8M	98.8M	114.8M	118.1M	152.6M	176M	78M
Stock-Based Compensation	5.6M	9.34M	10.2M	13.2M	17.4M	18.4M	17.7M	33.3M	14.8M	8.4M
Deferred Taxes	6.88M	25.27M	8.5M	-21.9M	8.9M	21.9M	-1.7M	131.5M	16.7M	5.1M
Other Non-Cash Items	28.11M	105.01M	58M	214.8M	40.4M	19M	86.7M	89.1M	78.3M	252.6M
Working Capital Changes	84.99M	33.16M	-68.8M	-55.3M	-149.1M	-102.3M	-62.3M	-118.9M	-110.4M	-53.5M
Change in Receivables	-60.62M	-22.82M	-23.5M	-46.6M	-32.1M	-35.3M	-47.2M	-72.1M	-53.8M	-58.6M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0
Cash from Investing	-783.45M	-128.86M	-85.2M	-88.4M	-331.7M	-307.9M	-225.6M	-488.5M	-246.6M	-183.6M
Capital Expenditures	-29.6M	-39.8M	-73.6M	-42.9M	-57.6M	-80.6M	-88.8M	-90.4M	-78.7M	-72M
CapEx % of Revenue	2.21%	2.25%	4.02%	2.31%	2.59%	3.17%	3.24%	2.9%	2.38%	-
Acquisitions	-755.1M	-87.6M	-11.4M	-104.6M	-280.4M	-228.7M	-128.9M	-378.8M	-162.1M	-118.5M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	1.25M	-1.46M	-200K	59.1M	6.3M	1.4M	-7.9M	-22.2M	7.5M	6.8M
Cash from Financing	767.72M	-6.3M	-135.9M	66.7M	316.3M	42.1M	-155.2M	262M	-57.3M	-143.4M
Debt Issued (Net)	565.13M	125.1M	-1.7M	213.1M	-43.8M	-644.2M	19.5M	450.4M	158.7M	66M
Equity Issued (Net)	-2M	-2M	0	0	581.8M	882.9M	0	0	0	0
Dividends Paid	-1.32M	-7.8M	0	0	-5.1M	0	0	0	0	0
Share Repurchases	-2M	-2M	0	0	0	0	0	0	0	0
Other Financing	205.91M	-121.6M	-134.2M	-146.4M	-216.6M	-196.6M	-174.7M	-188.4M	-216M	-209.4M
Net Change in Cash	11.77M▲ 0%	9.39M▼ 20.2%	-91.6M▼ 1075.1%	225.2M▲ 345.9%	71.7M▼ 68.2%	-107M▼ 249.2%	-87M▲ 18.7%	73.6M▲ 184.6%	-29.6M▼ 140.2%	-47M▲ 0%
Free Cash Flow	91.34M▲ 0%	104.8M▲ 14.7%	55.9M▼ 46.7%	204M▲ 264.9%	29.5M▼ 85.5%	78.2M▲ 165.1%	205M▲ 162.1%	209.7M▲ 2.3%	195.6M▼ 6.7%	208M▲ 0%
FCF Margin %	6.81%	5.92%	3.05%	10.97%	1.33%	3.08%	7.47%	6.73%	5.91%	6.22%
FCF Growth %	6.05%	14.73%	-46.66%	264.94%	-85.54%	165.08%	162.15%	2.29%	-6.72%	20.02%
FCF per Share	1.86	2.18	1.16	4.18	0.41	0.85	1.63	1.66	1.54	1.54
FCF Conversion (FCF/Net Income)	-2.28x	-0.70x	-1.73x	-2.13x	-1.23x	-2.91x	-24.69x	-1.79x	-3.52x	-2.73x
Interest Paid	0	145.4M	180.3M	203.6M	194.3M	218.7M	169.6M	199.7M	0	0
Taxes Paid	0	2.2M	1.6M	1.7M	1.5M	1.8M	1.4M	1.6M	0	0

SGRY Key Ratios

Surgery Partners, Inc. (SGRY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-6.38%	-16.89%	-5.35%	-6.99%	-3.61%	-1.96%	-0.36%	-4.8%	-2.18%	-2.39%
Return on Invested Capital (ROIC)	4.65%	1.73%	4.48%	3.05%	4.67%	4.65%	4.05%	3.93%	4.06%	4.06%
Gross Margin	24.41%	23.15%	23.14%	20.42%	22.08%	22.64%	23.6%	23.94%	23.12%	22.83%
Net Margin	-3.95%	-11.61%	-4.08%	-6.24%	-3.19%	-2.15%	-0.43%	-5.4%	-2.35%	-2.28%
Debt / Equity	1.64x	2.25x	1.71x	1.97x	1.43x	0.89x	0.91x	1.02x	1.14x	1.14x
Interest Coverage	1.70x	0.53x	1.31x	0.91x	1.37x	1.47x	1.70x	1.73x	1.43x	1.35x
FCF Conversion	-2.28x	-0.70x	-1.73x	-2.13x	-1.23x	-2.91x	-24.69x	-1.79x	-3.52x	-2.73x
Revenue Growth	17.09%	32.08%	3.38%	1.57%	19.62%	14.12%	8.03%	13.52%	6.24%	5.38%

SGRY SEC Filings & Documents

Surgery Partners, Inc. (SGRY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Dec 16, 2025·SEC

10-K Annual Reports

FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 7, 2025·SEC

FY 2024

Feb 26, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 5, 2026·SEC

FY 2025

Nov 10, 2025·SEC

FY 2025

Aug 5, 2025·SEC

SGRY Frequently Asked Questions

Surgery Partners, Inc. (SGRY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Surgery Partners, Inc. (SGRY) reported $3.34B in revenue for fiscal year 2025. This represents a 1075% increase from $284.6M in 2013.

Surgery Partners, Inc. (SGRY) grew revenue by 6.2% over the past year. This is steady growth.

Surgery Partners, Inc. (SGRY) reported a net loss of $76.1M for fiscal year 2025.

Dividend & Returns

Surgery Partners, Inc. (SGRY) has a return on equity (ROE) of -2.2%. Negative ROE indicates the company is unprofitable.

Surgery Partners, Inc. (SGRY) generated $208.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More SGRY

Surgery Partners, Inc. (SGRY) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Surgery Partners, Inc.(SGRY)Earnings, Financials & Key Ratios

SGRY Key Insights

✓Strengths

✗Weaknesses

SGRY Price & Volume

SGRY Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

SGRY Recent Earnings

SGRY Peer Comparison

Compare SGRY vs Peers

vs USPH

vs UNH

Compare Top 5

SGRY Income Statement

SGRY Balance Sheet

SGRY Cash Flow Statement

SGRY Key Ratios

SGRY SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

SGRY Frequently Asked Questions

Explore More SGRY

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation